MedTrace Logo

International Registry of Patients Treated With Pressurized IntraPeritoneal Aerosol Chemotherapy (PIPAC)

NCT03210298 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2019-10-08

No results posted yet for this study

Summary

Multicentric, international, web-based prospective documentation of the indications and results of Pressurized Aerosol Chemotherapy (so-called PIPAC or PITAC) for treating malignant pleural and peritoneal diseases. Indication is decided by the treating physician. There are no predefined inclusion or exclusion criteria.

Conditions

  • Peritoneum Cancer
  • Peritoneum Neoplasm
  • Pleural Cancer
  • Pleural Effusion
  • Pleural Mesothelioma
  • Ovarian Cancer
  • Gastric Cancer
  • Appendix Cancer
  • Pseudomyxoma Peritonei
  • Colorectal Cancer
  • Pancreas Cancer
  • Gallbladder Cancer
  • Ascites
  • CUP
  • Chemotherapeutic Toxicity

Interventions

COMBINATION_PRODUCT

PIPAC

A chemotherapeutic solution is aerosolized into the expanded abdominal cavity during laparoscopy, under pressure. This allows a relatively homogeneous repartition of the drug and an effective tissue penetration.

Sponsors & Collaborators

  • Ruhr University of Bochum

    collaborator OTHER

  • Sabine Rhode

    lead OTHER

Principal Investigators

  • Philipp Horvath, MD · University Hospital Tuebingen

Eligibility

Min Age
10 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2022-09-30
Completion
2022-09-30
FDA Drug
Yes

Countries

  • Argentina
  • Australia
  • Austria
  • Belgium
  • Denmark
  • France
  • Germany
  • Italy
  • Poland
  • Russia
  • Singapore
  • Spain
  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03210298 on ClinicalTrials.gov